NasdaqCM - Nasdaq Real Time Price USD

Profusa, Inc. (PFSA)

0.7272 -0.0437 (-5.67%)

As of 2:33:58 PM EDT. Market Open.

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

Profusa Receives ISO 13485:2016 Certificate from GMED

GlobeNewswire 15d ago

PFSA
-5.67%
Profusa ISO 13485 Certification Decision Advances Lumee Oxygen Platform Toward CE Mark

InvestorsHub 1mo ago

PFSA
-5.67%
Profusa, Inc. Receives Nasdaq Compliance Determination

GlobeNewswire 1mo ago

PFSA
-5.67%
Profusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares Requirement

GlobeNewswire 1mo ago

PFSA
-5.67%
^IXIC
Profusa Advances G3 Vision Labs Acquisition Conditions as Q2 Net Loss Widens

InvestorsHub 2mo ago

PFSA
-5.67%
Profusa Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with G3 Vision Labs, a Commercial Stage Diagnostics Company

GlobeNewswire 2mo ago

PFSA
-5.67%
Profusa vies for potential G3 Vision Labs acquisition

Medical Device Network 2mo ago

PFSA
-5.67%
Profusa Signs Term Sheet for Diagnostics Acquisition and Announces Leadership Changes

InvestorsHub 3mo ago

PFSA
-5.67%
Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics Company

GlobeNewswire 3mo ago

PFSA
-5.67%
Profusa Announces 1-for-25 Reverse Stock Split

GlobeNewswire 3mo ago

PFSA
-5.67%
^IXIC
Profusa Shareholders Approve Strategic Initiatives at 2026 Annual Meeting, Supporting PanOmics Acquisition, Balance Sheet Strengthening and Nasdaq Compliance Efforts

GlobeNewswire 4mo ago

PFSA
-5.67%
Profusa Submits Response Package to GMED as Part of Ongoing CE Mark Review Process for Lumee® Oxygen Platform

GlobeNewswire 4mo ago

PFSA
-5.67%

Performance Overview

Return	PFSA	S&P 500 (^GSPC)
YTD	-99.91%	+10.99%
1-Year	-99.96%	+11.36%
3-Year	-100.00%	+82.33%

U.S. markets close in 1h

Profusa, Inc. (PFSA)

Profusa Receives ISO 13485:2016 Certificate from GMED

Profusa ISO 13485 Certification Decision Advances Lumee Oxygen Platform Toward CE Mark

Profusa, Inc. Receives Nasdaq Compliance Determination

Profusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares Requirement

Profusa Advances G3 Vision Labs Acquisition Conditions as Q2 Net Loss Widens

Profusa Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with G3 Vision Labs, a Commercial Stage Diagnostics Company

Profusa vies for potential G3 Vision Labs acquisition

Profusa Signs Term Sheet for Diagnostics Acquisition and Announces Leadership Changes

Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics Company

Profusa Announces 1-for-25 Reverse Stock Split

Profusa Shareholders Approve Strategic Initiatives at 2026 Annual Meeting, Supporting PanOmics Acquisition, Balance Sheet Strengthening and Nasdaq Compliance Efforts

Profusa Submits Response Package to GMED as Part of Ongoing CE Mark Review Process for Lumee® Oxygen Platform